AQR Arbitrage’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

AQR Arbitrage’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-133,124	Closed	-$1.31M	–	1422
2022 Q3	$1.31M	Hold	133,124	–	–	0.03%	559
2022 Q2	$1.3M	Buy	133,124 +50,000	+60%	+$491K	0.03%	529
2022 Q1	$812K	Hold	83,124	–	–	0.02%	531
2021 Q4	$815K	Sell	83,124 -100,314	-55%	-$979K	0.02%	716
2021 Q3	$1.78M	Buy	183,438 +52,040	+40%	+$504K	0.05%	310
2021 Q2	$1.27M	Buy	+131,398	New	+$1.28M	0.04%	386

AQR Arbitrage's SHAC Position: Q4 2022 in Review

AQR Arbitrage sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 133,124 shares — an estimated $1.31M sold.

AQR Arbitrage first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $1.78M in Q3 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

AQR Arbitrage reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 133,124 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.31M.
AQR Arbitrage first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
AQR Arbitrage's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.78M in Q3 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.